Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

NYSE:CLH - New York Stock Exchange, Inc. - US1844961078 - Common Stock - Currency: USD

226.51  -1.21 (-0.53%)

After market: 226.51 0 (0%)

Fundamental Rating

5

Taking everything into account, CLH scores 5 out of 10 in our fundamental rating. CLH was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and the financial health of CLH get a neutral evaluation. Nothing too spectacular is happening here. CLH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CLH had positive earnings in the past year.
In the past year CLH had a positive cash flow from operations.
In the past 5 years CLH has always been profitable.
CLH had a positive operating cash flow in each of the past 5 years.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.40%, CLH is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
CLH has a better Return On Equity (15.21%) than 73.49% of its industry peers.
CLH's Return On Invested Capital of 7.88% is fine compared to the rest of the industry. CLH outperforms 63.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLH is below the industry average of 10.89%.
Industry RankSector Rank
ROA 5.4%
ROE 15.21%
ROIC 7.88%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of CLH (6.58%) is better than 73.49% of its industry peers.
CLH's Profit Margin has improved in the last couple of years.
CLH's Operating Margin of 11.04% is fine compared to the rest of the industry. CLH outperforms 75.90% of its industry peers.
CLH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 30.76%, CLH is in line with its industry, outperforming 50.60% of the companies in the same industry.
CLH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.04%
PM (TTM) 6.58%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLH is creating some value.
CLH has about the same amout of shares outstanding than it did 1 year ago.
CLH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLH has a worse debt to assets ratio.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CLH has an Altman-Z score of 3.39. This indicates that CLH is financially healthy and has little risk of bankruptcy at the moment.
CLH has a Altman-Z score of 3.39. This is in the better half of the industry: CLH outperforms 67.47% of its industry peers.
CLH has a debt to FCF ratio of 8.22. This is a slightly negative value and a sign of low solvency as CLH would need 8.22 years to pay back of all of its debts.
The Debt to FCF ratio of CLH (8.22) is better than 62.65% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that CLH has dependencies on debt financing.
CLH has a Debt to Equity ratio of 1.08. This is in the lower half of the industry: CLH underperforms 66.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.22
Altman-Z 3.39
ROIC/WACC0.95
WACC8.29%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.37 indicates that CLH has no problem at all paying its short term obligations.
CLH has a Current ratio of 2.37. This is in the better half of the industry: CLH outperforms 75.90% of its industry peers.
A Quick Ratio of 1.98 indicates that CLH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.98, CLH belongs to the top of the industry, outperforming 80.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.98
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

CLH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.34%.
Measured over the past years, CLH shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.46% on average per year.
CLH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.52%.
Measured over the past years, CLH shows a quite strong growth in Revenue. The Revenue has been growing by 11.54% on average per year.
EPS 1Y (TTM)4.34%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-15.5%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%4.01%

3.2 Future

CLH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.71% yearly.
Based on estimates for the next years, CLH will show a small growth in Revenue. The Revenue will grow by 5.49% on average per year.
EPS Next Y3.52%
EPS Next 2Y10.81%
EPS Next 3Y15.96%
EPS Next 5Y12.71%
Revenue Next Year3.85%
Revenue Next 2Y4.61%
Revenue Next 3Y5.35%
Revenue Next 5Y5.49%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

CLH is valuated quite expensively with a Price/Earnings ratio of 31.37.
Compared to the rest of the industry, the Price/Earnings ratio of CLH is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CLH to the average of the S&P500 Index (25.82), we can say CLH is valued slightly more expensively.
With a Price/Forward Earnings ratio of 24.86, CLH is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as CLH.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CLH is valued at the same level.
Industry RankSector Rank
PE 31.37
Fwd PE 24.86
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CLH's Enterprise Value to EBITDA is on the same level as the industry average.
CLH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 36.27
EV/EBITDA 13.43
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLH does not grow enough to justify the current Price/Earnings ratio.
CLH has a very decent profitability rating, which may justify a higher PE ratio.
CLH's earnings are expected to grow with 15.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.9
PEG (5Y)1
EPS Next 2Y10.81%
EPS Next 3Y15.96%

0

5. Dividend

5.1 Amount

CLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAN HARBORS INC

NYSE:CLH (5/23/2025, 9:23:24 PM)

After market: 226.51 0 (0%)

226.51

-1.21 (-0.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners92.22%
Inst Owner Change-1.98%
Ins Owners5.93%
Ins Owner Change1.18%
Market Cap12.28B
Analysts81.18
Price Target257.56 (13.71%)
Short Float %1.66%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.06%
Min EPS beat(2)1.24%
Max EPS beat(2)12.88%
EPS beat(4)3
Avg EPS beat(4)4.91%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)6
Avg EPS beat(8)2.12%
EPS beat(12)10
Avg EPS beat(12)9.57%
EPS beat(16)14
Avg EPS beat(16)13.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-1.17%
Revenue beat(12)7
Avg Revenue beat(12)0.7%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)-4.2%
PT rev (3m)-8.79%
EPS NQ rev (1m)1.7%
EPS NQ rev (3m)-7.01%
EPS NY rev (1m)1.25%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.35%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-1.95%
Valuation
Industry RankSector Rank
PE 31.37
Fwd PE 24.86
P/S 2.06
P/FCF 36.27
P/OCF 16.14
P/B 4.77
P/tB 30.32
EV/EBITDA 13.43
EPS(TTM)7.22
EY3.19%
EPS(NY)9.11
Fwd EY4.02%
FCF(TTM)6.25
FCFY2.76%
OCF(TTM)14.04
OCFY6.2%
SpS109.69
BVpS47.44
TBVpS7.47
PEG (NY)8.9
PEG (5Y)1
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 15.21%
ROCE 10.47%
ROIC 7.88%
ROICexc 8.7%
ROICexgc 14.08%
OM 11.04%
PM (TTM) 6.58%
GM 30.76%
FCFM 5.69%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexcg growth 3Y10.92%
ROICexcg growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.22
Debt/EBITDA 2.58
Cap/Depr 101.08%
Cap/Sales 7.1%
Interest Coverage 4.14
Cash Conversion 70.83%
Profit Quality 86.54%
Current Ratio 2.37
Quick Ratio 1.98
Altman-Z 3.39
F-Score7
WACC8.29%
ROIC/WACC0.95
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)4.34%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-15.5%
EPS Next Y3.52%
EPS Next 2Y10.81%
EPS Next 3Y15.96%
EPS Next 5Y12.71%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%4.01%
Revenue Next Year3.85%
Revenue Next 2Y4.61%
Revenue Next 3Y5.35%
Revenue Next 5Y5.49%
EBIT growth 1Y6.39%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year75.15%
EBIT Next 3Y28.22%
EBIT Next 5Y20.01%
FCF growth 1Y1.22%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y9.82%
OCF growth 3Y12.52%
OCF growth 5Y13.49%